CSP — Consumer Issues/Safety/Products
FDA issues drug and device shortages
Lobbyists: ALICIA KERRY MICA
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
1st Quarter - Report · 2026
- Filing UUID
e8132bc6-6d5e-4d06-97b0-7f9c472cbde8- Type
Q1— 1st Quarter - Report- Period
- first_quarter
- Year
- 2026
- Posted
- 2026-04-16 15:37:06
- Income (reported)
- —
- Expenses (reported)
- $118,000
- Expenses method
- A
- Filing document
- Open on lda.senate.gov
Registrant (lobbying firm)
- Contact
- ALICIA KERRY J. MICA
- Phone
- +1 202-805-3624
- Address
- zip:18018, city:Bethlehem, state:PA, street:824 12th Avenue
Client
Manufacturing
- State
- PA
- Country
- US
- Effective date
- 2022-10-01
Issues lobbied + lobbyists
HCR — Health Issues
generic pharmaceutical and medical device issues
Lobbyists: ALICIA KERRY MICA
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
TAR — Tariff (miscellaneous tariff bills)
drug and device shortage issues
Lobbyists: ALICIA KERRY MICA
Government entities lobbied: Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; SENATE; U.S. Trade Representative (USTR)
PHA — Pharmacy
drug quality security act, 503A and 503B pharmacy issues
Lobbyists: ALICIA KERRY MICA
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE